These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18326407)

  • 1. [Saliva and intensity modulated radiotherapy].
    Roesink JM; Terhaard CH; Raaijmakers CP
    Ned Tijdschr Tandheelkd; 2008 Feb; 115(2):107-10. PubMed ID: 18326407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS; Weber RS; Garden AS
    J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose and volume impact on radiation-induced xerostomia.
    Marmiroli L; Salvi G; Caiazza A; Di Rienzo L; Massaccesi M; Murino P; Macchia G
    Rays; 2005; 30(2):145-8. PubMed ID: 16294907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research advances in prevention of radiation induced xerostomia by intensity-modulated radiation therapy].
    Yan C; Wang ZH
    Shanghai Kou Qiang Yi Xue; 2008 Oct; 17(5):540-4. PubMed ID: 18989600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA
    Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.
    Li Y; Taylor JM; Ten Haken RK; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):660-9. PubMed ID: 17141973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients.
    Malouf JG; Aragon C; Henson BS; Eisbruch A; Ship JA
    Cancer Detect Prev; 2003; 27(4):305-10. PubMed ID: 12893079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
    Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
    Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer.
    Chao KS
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):20-5. PubMed ID: 11917280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial irradiation of the parotid gland.
    Eisbruch A; Ship JA; Kim HM; Ten Haken RK
    Semin Radiat Oncol; 2001 Jul; 11(3):234-9. PubMed ID: 11447580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In regard to Münter et Al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. (Int j radiat oncol biol phys 2007;67:651-659).
    Messerschmidt GL; Oleka N
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1651-2; author reply 1652. PubMed ID: 18035221
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
    Houweling AC; Philippens ME; Dijkema T; Roesink JM; Terhaard CH; Schilstra C; Ten Haken RK; Eisbruch A; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1259-65. PubMed ID: 20005639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.
    van Luijk P; Pringle S; Deasy JO; Moiseenko VV; Faber H; Hovan A; Baanstra M; van der Laan HP; Kierkels RG; van der Schaaf A; Witjes MJ; Schippers JM; Brandenburg S; Langendijk JA; Wu J; Coppes RP
    Sci Transl Med; 2015 Sep; 7(305):305ra147. PubMed ID: 26378247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parotid-gland-sparing 3D conformal radiotherapy in patients with bilateral radiotherapy of the head and neck region--results in clinical practice.
    Hey J; Setz J; Gerlach R; Janich M; Sehlleier S; Schaller HG; Gernhardt CR; Kuhnt T
    Oral Oncol; 2009 Feb; 45(2):e11-7. PubMed ID: 18621572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
    Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
    Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.